News & Analysis on Clinical Trial Services & Contract Research And Development
Lonza: small-molecule collaboration arrangement
By Jenni Spinner
- Last updated on
Venture capital firm and joint venture partner BioGeneration Ventures have joined with Lonza in an extension of their collaboration focused on development and manufacturing of small molecules. This marks an expansion of the current arrangement, in which Lonza provides customized services to Forbion and BGV’s large-molecule biologics portfolio companies.
Under the terms of the agreement, Lonza will provide early development services and scalable manufacturing for small molecules. The offering reportedly covers drug substance development, particle engineering development, oral solid drug product development and regulatory services.